Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early eplerenone after acute ST-elevation myocardial infarction
NL-OMON36477Phase 4Active, not recruiting
- Sponsor
- Pfizer
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Eplerenone with Placebo (2 arms). Primary endpoint: Time to first composite cardiovascular event. Started Jun 2011; status: active, not recruiting.
02
Drugs
eplerenone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON36477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36477.